Generic Salmeterol/Fluticasone HFA pMDI
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Generic Salmeterol/Fluticasone HFA pMDI, covering 2013-09-19 to 2013-09-19. Get the full timeline:
Most recent: Clinical Trial Update: Compare the Effects of Seretide® Evohaler and a Generic Salmeterol/Fluticasone Hydrofluoroalkane (HFA) Pressurized Metered-dose Inhaler (pMDI) on Functional Respiratory Imaging Parameters in Asthmatic Patients [Phase 3]